HIF1A and neoplasm: Several well-described pro-tumor properties of CAFs are mediated through hypoxia-inducible-factor-1 (HIF1), a pathway that drives oncogenesis in kidney cancer and is upregulated in the majority of ccRCC tumors via alteration of the von-Hippel Lindau (VHL) gene [7].